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Abstract
Background: Shared Pathology Informatics Network (SPIN) is a tissue resource initiative that utilizes clinical reports
of the vast amount of paraffin-embedded tissues routinely stored by medical centers. SPIN has an informatics component
(sending tissue-related queries to multiple institutions via the internet) and a service component (providing
histopathologically annotated tissue specimens for medical research). This paper examines if tissue blocks, identified by
localized computer searches at participating institutions, can be retrieved in adequate quantity and quality to support
medical researchers.
Methods: Four centers evaluated pathology reports (1990–2005) for common and rare tumors to determine the
percentage of cases where suitable tissue blocks with tumor were available. Each site generated a list of 100 common
tumor cases (25 cases each of breast adenocarcinoma, colonic adenocarcinoma, lung squamous carcinoma, and prostate
adenocarcinoma) and 100 rare tumor cases (25 cases each of adrenal cortical carcinoma, gastro-intestinal stromal tumor
[GIST], adenoid cystic carcinoma, and mycosis fungoides) using a combination of Tumor Registry, laboratory information
system (LIS) and/or SPIN-related tools. Pathologists identified the slides/blocks with tumor and noted first 3 slides with
largest tumor and availability of the corresponding block.
Results: Common tumors cases (n = 400), the institutional retrieval rates (all blocks) were 83% (A), 95% (B), 80% (C),
and 98% (D). Retrieval rate (tumor blocks) from all centers for common tumors was 73% with mean largest tumor size
of 1.49 cm; retrieval (tumor blocks) was highest-lung (84%) and lowest-prostate (54%).
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Retrieval rate (tumor blocks) from all centers for rare tumors was 66% with mean largest tumor size of 1.56 cm; retrieval
(tumor blocks) was highest for GIST (72%) and lowest for adenoid cystic carcinoma (58%).
Conclusion: Assessment shows availability and quality of archival tissue blocks that are retrievable and associated
electronic data that can be of value for researchers. This study serves to compliment the data from which uniform use
of the SPIN query tools by all four centers will be measured to assure and highlight the usefulness of archival material
for obtaining tumor tissues for research.
Background
Repositories of clinically annotated human tissue speci-
mens are vitally important to biomedical researchers[1,2].
In the past, tissue repositories were created prospectively
by collecting samples of pre-determined types of lesions
excised during surgical procedures. Such repositories are
very expensive to create and are usually difficult to man-
age after their initial funding period terminates without
additional resources. The Shared Pathology Informatics
Network (SPIN) is a National Cancer Institution (NCI)-
funded multi-institutional initiative designed to utilize
the vast amounts of routinely stored paraffin-embedded
tissue blocks as a ready-made tissue repository that can be
automatically searched for blocks and data appropriate
for many kinds of research efforts[3].
There are large collections of archived paraffin tissue
already in existence for which many pathology laborato-
ries have at least ten years of pathology reports stored elec-
tronically[4]. It is important to emphasis that these
archived tissues are collected and stored at the time of rou-
tine diagnostic pathology services, whereas, most tissue
bank collections are made up of targeted specimens that
are specific to an organ system or tumor of interest.
Searchable databases with clinical data on patients also
exist at hospitals and medical institutions. Consequently,
as part of the SPIN feasibility study, hospitals affiliated
with Harvard University, Indiana University, University of
California Los Angeles, and the University of Pittsburgh
that make up the SPIN have developed a tool that is a
working, freely distributable prototype for identification
of available tissue specimens across nationally distributed
tissue archives[5]. Prior to a full-scale implementation of
the tool at the study sites, a feasibility study was necessary
to determine whether or not the available specimens
retrievable were of significant quality for performing
research studies.
It has been estimated that pathology laboratories process
50 million specimens every year and it is possible that
institutions in the U.S. have warehoused more than 300
million specimens[6]. While formalin fixed, paraffin
embedded tissues are remarkably resilient and permit
long term storage and retrieval for research use[4,7,8],
there is a paucity of information on the quality and avail-
ability of such tissues. In the great majority of medical
centers, it is not a priority to determine what is the nature
and accessibility of the paraffin archives. While there is a
general opinion that the archive may be valuable, once a
case is signed out little work is done to control inventory,
optimize storage locations and perform general quality
assurance and quality control (QA/QC).
The first five years of funding for the SPIN effort was a fea-
sibility study to determine if the tissue data (from elec-
tronic surgical pathology reports) could be successfully
queried and if the quality and numbers of tissue blocks
and clinical/pathology annotation would be adequate for
researchers. The purpose of the present study is to assess
the availability and quality of paraffin blocks that are
identified by whatever means are chosen locally (i.e. the
SPIN system or other local laboratory information sys-
tems (LIS) computer searches) based on a sampling
approach. In order for the SPIN tool to be successfully
used, the tissues must not only be identified, but the
research team must also be provided with a realistic esti-
mate of the availability and quality of the tissue. The
objectives of this study therefore were (1) to obtain a sam-
ple of pathology reports and determine the percentage of
cases where an institution can find the associated glass
slides and/or tissue blocks for which tumor is still availa-
ble for research purposes and (2) to determine the availa-
bility and quality of paraffin blocks that are identified by
each institute's optimal search procedure.
Methods
Case selection and sampling approach
The focus of this study was the retrieval rates of quality
paraffin blocks with the presence of tumor material from
surgical pathology reports containing a cancer diagnosis.
Thus, the target sample of pathology reports was limited
to cases where adequate excised specimens could be avail-
able and reported the presence of certain cancer diagnoses
in two major categories. The criteria used for the common
tumor category consisted of 100 cases of the most com-
mon epithelial tumors (25 each from breast adenocarci-
noma, colonic adenocarcinoma, lung squamous
carcinoma, and prostate adenocarcinoma) collected
between 1990 and 2005. The rare tumor criteria consisted
of 100 rare or uncommon tumors (25 cases each of adre-Page 2 of 14
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[GIST], adenoid cystic carcinoma, and mycosis fungoides)
collected between 1990 and 2005. The work for this study
was performed under the auspices of University of Pitts-
burgh IRB #0304081 and associated IRBs at the partnering
institutions (Harvard, Indiana University and UCLA).
Consensus about the final list of tumor types was reached
by the SPIN investigators. In particular, the list of tumor
types originally selected for the rare tumor cases were
adrenal cortical carcinoma, gastrointestinal stromal
tumor (GIST), choriocarcinoma and retinoblastoma. We
had limited success with the initial search of these rare
tumors because there was site-specific variability in terms
of obtaining the required number of cases. Specifically, at
institutes having cases triaged at hospitals targeted to spe-
cific patient populations, such as children's and women's
hospitals, there was a paucity of data retrieval for those
specialized cancer cases, thus the above revised list for rare
tumors was used for this study.
The year 1990 was chosen as the initial time frame for case
identification because of two primary reasons. First, the
fact that most of the SPIN member institutions electronic
pathology record system was implemented by the late
1980s. It was essential to have the electronic pathology
reports to demonstrate that the SPIN tools for identifying
cases can utilize them. Second, the authors wanted to
demonstrate the value for potential researchers that may
use the SPIN tools and its advantage when linked to other
electronic databases by presenting the retrieval rates of
blocks and slides that would have at least 5–10 years of
follow up data in other medical records. A SPIN patholo-
gist randomly selecting cases for each year for initial
screening and verification in order to select the first 100
eligible cases in each major category accomplished this.
Also, an extra five-year time frame was added to allow
every site to increase its chances of finding adequate
number of rare tumor cases.
Each of the four SPIN institutions (Harvard, Indiana Uni-
versity, UCLA and U Pitt) was expected to randomly iden-
tify cases for the two major categories by the most
accessible and widely available tools locally. These
included the surgical pathology laboratory information
system or LIS, Tumor Registry or SPIN-related informatics
tools. It is important to note that each institution has dif-
ferent databases and specimen query mechanisms to iden-
tify cases of interest by default, and as such, the different
methods used to identify cases are part of the routine
workflow and represent each site's optimal search proce-
dure. For example, for identifying the common tumors,
while other institutions used the aforementioned meth-
ods, Harvard utilized primarily the SPIN tools for case
finding which identified the most current cases that were
undemanding to retrieve from on-site archives rather than
off-site storage facilities. Thus, this manuscript primarily
highlights the retrievable rates of quality archived paraffin
blocks with the presence of tumor for research studies and
not the method by which blocks were identified.
SPIN study data forms
All data were recorded on a pre-defined Excel worksheet
that was distributed to each lead pathologist at the begin-
ning of this study. The Excel data forms had three sections
that were filled by the project coordinator, tissue banker/
technician that retrieved the slides/blocks, and the pathol-
ogist that reviewed the slides/blocks for tumor. The form
consisted of a dropdown list of pre-defined choices for
each data cell within the three sections.
The Coordinator distributed the Excel data form with pre-
filled data cells for the four tumor types in the two major
categories. The tissue banker acted as an honest broker
who noted information about hospital and institution
affiliations for locating the slides/blocks as well as the
associated surgical pathology accession number as identi-
fied via each institutions preferred methods.
Specimen Retrieval
Once the final 100 cases in each major category were iden-
tified, all reports were printed for final verification. Tissue
bankers and/or histotechnologists searched for slides and
blocks in the archives files; accessing either the on-site or
off-site (warehoused) case materials. If the case was miss-
ing, and there was a tracking tag inserted in the file, tissue
bankers attempted to track it down from the investigator
who had utilized the materials. If the case was missing and
there was no tracking tag, then the search stopped with the
assumption that the block was unavailable. If the case was
found, the material was then brought to the laboratory
where it was inventoried and the data entered into the
SPIN study data forms. Specifically, the tissue bankers
noted the number of slides/blocks reported on the pathol-
ogy report, in addition to the number of slides/blocks that
they were actually able to retrieve from the pathology
archives. If any slides/blocks were not retrieved, a com-
ment section was provided to document why they were
missing or if they were currently being used for other stud-
ies/investigators. The cases were then transferred to a
study pathologist for review, along with copies of the par-
tially completed Excel data forms.
Specimen Review
Cases were reviewed by multiple pathologists in accord-
ance with the standardized review protocol, and tabulated
into the study data forms. The pathologists initially
reviewed all the retrieved slides associated with a case and
noted the total number of available slides/blocks with the
presence of tumor. The size in diameter of the tumor wasPage 3 of 14
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tumor size were noted. The availability of the correspond-
ing blocks in these 3 slides was also noted. In cases where
slides were missing but blocks were found, new slides
were not re-cut but a visual examination of the blocks was
noted. For quality assessment, in 15% of randomly
selected cases, the pathologist matched the outlines of the
tissue in the paraffin blocks to the glass slides to deter-
mine the amount of tissue remaining in the paraffin
block. The amount of tissue present on the blocks was vis-
ually examined for adequacy.
A lead pathologist who reviewed the data for complete-
ness reconsolidated the completed data files into one file.
The Excel data template with its resultant data set was fur-
ther processed by an anonymizer, which substituted a
code number for the locally available surgical accession
number. Final de-identified data were electronically for-
warded to the Pittsburgh contingent of the SPIN consor-
tium for final analysis.
Results
Retrieval of common tumors
The summary of the available blocks and slides for the
common tumor cases (n = 400) from the combined tissue
archives of the four SPIN member institutions is shown in
Table 1. Figure 1a illustrates the average number of paraf-
fin embedded blocks/case (all blocks) that were available
in the archives in parallel with the average number of
tumor blocks/case that had been examined from all sites
involving the search of common tumors. Of note, at least
73% of the cases found had between 1–14 blocks/case
with tumor tissue available for potential research use.
For common tumors, the overall case retrieval was highest
for lung (94%) and breast (93%), followed by colon
(85%) and prostate (83%), as described in Table 2. Table
3 shows that each institution's case retrieval rates (all
blocks) were 98% (UCLA), 95% (Indiana), 83% (Har-
vard), and 80% (Pitt), along with the percentage of cases
with at least ≥1 block with presence of tumor tissue. Cor-
respondingly, of the total blocks that were retrieved and
examined from the archives, Table 4 shows the percentage
of blocks with tumor present to be highest for lung (96%)
and prostate (91%) followed by breast (88%) and colon
(86%). UCLA (98%) and Indiana (95%) had the greatest
percentage of blocks with tumor tissue found and are fol-
lowed by Pittsburgh (85%) and Harvard (83%).
Although many of the cases did have paired blocks and
slides with tumor available, Figure 2a shows that there
were 64 cases that had only slides with tumor available
but no matching blocks were available; 22 cases had nei-
ther the slides nor the blocks. Retrieval rate for tumor
blocks from all centers for common tumors was 73% with
a mean largest tumor size of 1.49 cm, which is revealed in
Table 5. The number of cases retrieved for the common
tumor types by the original year of accession is shown in
Figure 3a and 3b, showing the distribution across the
SPIN institutions and across common tumor types,
respectively. Specimens retrieved and evaluated for the
common tumors encompassed cases accessioned from
1990–2005 with 64% being at least 10 years old.
Retrieval of rare tumors
The summary of the available blocks and slides for the
rare tumor cases (n = 400) from the tissue archives of the
four SPIN member institutions is shown in Table 6. Figure
1b illustrates the average number of total blocks/case
Table 1: Availability of slides/blocks from tissue archives for common tumors. Summary of the availability of slides and blocks retrieved 
from all SPIN sites with a breakdown of the number of blocks with presence of tumor for cases in the common tumor type category.
Quantity # of cases found on 
search: slides 
available by path 
report
# of cases found on 
search: slides found in 
archive
# of cases found on 
search: blocks 
available by path 
report
# of cases found on 
search: all blocks 
found in archive
# of cases found on 
search: Blocks w/
Tumor found in 
archive
n/a* 104 0 4 0 97
0 0 86 1 44 10
1 – 3 14 24 17 19 115
4 – 6 10 13 11 19 106
7 – 9 15 28 29 29 48
10 – 14 59 63 104 99 22
15 – 19 74 76 109 99 2
20 – 29 99 86 109 77 0
30 – 39 20 23 14 13 0
>40 5 1 2 1 0
400 400 400 400 400
n/a * = not available, blocks only, no tumor seenPage 4 of 14
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Average blocks found per case from tissue archivesFigure 1
Average blocks found per case from tissue archives. Illustration of the availability of the cases found by all SPIN sites 
involving the search for (a) the common tumor type and (b) the rare tumor type categories. The breakdown of the average 
number of all blocks found per case after the initial search from the archives are compared to the number of blocks found with 
presence of tumor.
g
a) Blocks found per case for common tumors 
Common Tumors from ALL sites (400 cases)
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Blocks found per case
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# of cases found on search: 
All Blocks
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n/a * = not available, blocks 
only, no tumor seen
b) Blocks found per case for rare tumors
Rare Tumors from ALL Sites (n = 400)
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only, no tumor seen
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of blocks that showed presence of tumor tissue per case.
Of significance is the fact that at least 64% of the cases
found had between 1–14 blocks/case with tumor tissue
available for potential research use.
Among the rare tumors, the overall case retrieval was high-
est for mycosis fungoides (83%) and GIST (82%) fol-
lowed by adrenal cortical carcinoma (71%) and adenoid
cystic carcinoma (66%), as described in Table 7. Table 8
shows that each institution's case retrieval rates (all
blocks) were 84% (UCLA), 78% (Harvard), 73% (Indi-
ana), and 67% (Pitt), along with the percentage of cases
with the presence of tumor tissue in 1 or more block per
case. Correspondingly, Table 9 shows from the total
blocks examined, the retrieval rate for the blocks with
tumor present to be highest for GIST (80%) and mycosis
fungoides (77%) followed by adrenal cortical carcinoma
(68%) and adenoid cystic carcinoma (58%). UCLA and
Indiana both (76%) presented with the greatest percent-
age of blocks with tumor found, followed by Harvard
(70%) and Pittsburgh (61%).
Although many of the cases did have paired blocks and
slides with tumor available, Figure 2b shows that there
were 11 cases that had slides with tumor available but no
matching blocks, and 82 cases had neither the slides nor
the blocks. The retrieval rate for tumor blocks from all
centers for rare tumors was 66% with a mean largest
tumor size of 1.56 cm, revealed in Table 10. The number
of cases retrieved for the rare tumor types by the original
year of accession is seen in Figure 4a and 4b, showing the
distribution by the SPIN institutions and by the rare
tumor types, respectively. Specimens retrieved and evalu-
ated for the rare tumors encompassed cases accessioned
from 1988–2005 with 62% greater than 5 years old.
Discussion
Advances in proteomics and genomics technologies have
led to a multitude of opportunities for research, the
majority of which require high quality tissue specimens
with associated annotation data[4,9,10]. Pathology
reports and the clinical data contained within them are a
valuable resource and an historically relatively underuti-
lized method of obtaining the vast amount of tissue sam-
ples from existing paraffin archives for potential use in
many of these research, educational and clinical projects
[10-14]. With advances in information system technolo-
gies, more sophisticated resources have become available
for data mining the rich textual information from archival
pathology reports[4,15]. Although the importance of uti-
lizing novel informatics techniques within pathology
departments has been previously reported, there is little
literature on the quality and availability of archived tissue
collections[4]. As a precursor to a successful use of SPIN
tools on a larger scale, we have analyzed a sample of
pathology reports to determine the percentage of these
reports for which we can find the associated tissue blocks
with cancer that are still available for research purposes
and which are retrievable from the warehouses.
Archived formalin-fixed paraffin-embedded tissue blocks
are generally labeled with unique accession numbers and
are remarkably resilient, which permits long-term storage
and retrieval for research use. These resources are often
managed locally by anatomic pathology laboratories and
generate a wealth of material via routine diagnostic
workups, particularly from resources associated with large
academic centers which have larger collections and the
expertise to report on rare tumors and classify new diag-
nostic markers for the common entities[4]. With the
advent of advances in molecular biology tools, materials
from archived paraffin blocks are amenable to extracting
high quality biological material for use in proteomics and
genomics projects[8]. Thus, if we can successfully identify
blocks in significant numbers in quantity as well as qual-
ity for research use across multiple institutions, then
implementation of tools like those developed by the SPIN
could process electronic pathology reports that would dra-
matically increase the value of these collections.
In efforts to accelerate the pace of discovery for research-
ing the genetic underpinnings of diseases, the National
Cancer Institute (NCI) has sponsored several tissue anno-
tation and banking efforts at the nationwide level[8,16-
20]. However, many of these collections use labor-inten-
sive manual processes to identify cases from archived tis-
sue collections and legacy databases. The solution that the
Table 2: Retrieval rates for common tumors. Retrieval rate from all SPIN sites for the common tumor type category: (a) Percentage 
case retrieval by each common tumor type (cases/total cases). Case retrieval rate for each tumor types in the common tumors 
category. (cases/total cases)
n = 100 n = 100 n = 100 n = 100 n = 400
Breast Colon Lung Prostate ALL Common Cases
% case retrieval (all blocks) 93% 85% 94% 84% 89%
% case retrieval (Blocks with Tumor) 74% 81% 84% 54% 73%Page 6 of 14
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can be run via the internet at participating institutions in
a HIPAA-compliant manner after agreeing with the bylaws
of the consortium and approval of other members[3].
Currently, many of the SPIN members are intimately
involved with enhancing many of the prototype SPIN
tools created by this group by working with the Cancer
Text Information Extraction System (CaTIES) project of
the NCIs Cancer Bioinformatics Grid (caBIG) initiative.
This relationship allows a common framework by which
the SPIN institutions can integrate their data with the
caBIG community.
In brief description, the mechanisms of how the SPIN
tools function are best described by 4 major tasks per-
formed prior to the data being searchable within a peer-
to-peer model. First, scrubbing of electronic records by
using a de-identification program would remove any
HIPAA identifiers. Second, the reports are parsed into
fields or chucks specified in the SPIN XML scheme. These
fields are items such as clinical history, gross description,
microscopic description, etc. Third, the text for each of
these chunks is autocoded so that all the medical concepts
contained in the text could receive a code derived from a
standard unencumbered vocabulary. And finally, a strat-
egy is devised to query this information by preserving the
intended context of a report in the autocoded product
(e.g. dealing with negatives, connecting organ sites with
their appropriate modifiers or morphologies). Many of
these functional and technical components that are uti-
lized by the SPIN tools have been described elsewhere
[21-27].
Because the number of available cases varied between
institutions based on the expertise and patient population
of a particular hospital, it was important for this study to
examine the number of cases that could be retrieved from
the four most common tumors and a sampling of rare
tumor types at all of the SPIN institutions to normalize
the specimen sampling. A correlation was seen with the
expertise of the institute's pathology and surgical units in
terms of locating more cases from those institutes that had
a higher frequency of resections in the diagnosis of inter-
est. An example of this was at Indiana University, which
had a very large number of choriocarcinoma cases because
of their expertise in the area of testicular tumors. Simi-
larly, at institutes that focused on certain types of cancers
for research only, we found that the attrition rates of
blocks for those organs of interest was higher because
many of their cases were being utilized by local investiga-
tors or sent out to outside investigators via collaborative
projects. For example, the University of Pittsburgh has a
large research focus on prostate cancer and it also partici-
pates in the Cooperative Prostate Cancer Tissue Resource
Table 4: Retrieval rates for common tumors. Retrieval rate from all SPIN sites for the common tumor type category: breakdown by 
each common tumor type at each institution (tumor blocks/all blocks). Retrieval rate for blocks with the presence of tumor for each 
common tumor type category at each SPIN institution. (tumor blocks/all blocks)
n = 25 n = 25 n = 25 n = 25 n = 100
SPIN INSTITUTIONS Breast Colon Lung Prostate ALL Common Tumors
PITTSBURGH 76% 96% 84% 84% 85%
UCLA 100% 92% 100% 100% 98%
INDIANA 88% 92% 100% 100% 95%
HARVARD 88% 64% 100% 80% 83%
ALL SPIN SITES 88% 86% 96% 91% 90%
Table 3: Retrieval rates for common tumors. Retrieval rate from all SPIN sites for the common tumor type category: percentage case 
retrieval by each SPIN institution (cases/total cases); Case retrieval rate at each SPIN institution for common tumors. (cases/total 
cases)
n = 100 n = 100 n = 100 n = 100
Pitt UCLA IU Harvard
% case retrieval (all blocks) 80% 98% 95% 83%
% case retrieval (Blocks with Tumor) 71% 94% 54% 74%Page 7 of 14
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tion rates for blocks with prostate cancer tissue.
Using the local preferred methods for case identification,
such as the routine use of the LIS or cancer registry tools,
was undemanding because it utilized the existing work-
flows and personnel without involving the SPIN tool and
personnel. However, this varied method did mark differ-
ences of how cases were initially identified and thus which
cases were selected for the standardized pathology review.
For example, one institution included outside referral
cases only for rare tumor category but not the common
tumors; other institutions excluded outside referral cases
altogether during their case selection process. These
assorted "routine" methods normally used at various
institutions bring to surface many issues that still need to
be addressed or resolved and are one of the key barriers for
advancing translational research, the lack of quality
biospecimens and its access. Compounding these issues
and ultimately leading to delays in study completions are
fundamental incompatibilities in the inter-institutional
research guidelines and protocols. This highlights the
importance of implementing informatics solutions that
are standardized and have common tools, methods and
vocabularies for identifying cases within a network of
institutions that participate and agree to share their large
archives of paraffin blocks.
Many investigators are also limited by the number of sam-
ples available for performing powerful statistical studies
within their own institutions, especially for the rare tumor
types. Thus, it is critical to develop and evaluate tools that
are able to open up the vast available archives for sharing
between institutions and provide the research community
with efficacious information on these tools in order to
increase the number of specimens that are available with
relative ease of accessibility, but without ceding on the
autonomy or control of each participating site[24,26,29].
Furthermore, even if the retrieval rates of this study hold
constant, as shown in Tables 2, 3, 4 and 7, 8, 9, against the
approximately 300 million specimens currently stored in
pathology archives [6], the sheer number of cases that
could be available for researchers demonstrates the neces-
sity and value of developing such tools that the SPIN envi-
sions. For example, if it is assumed that 1% (3 million) of
all specimens banked were rare tumors, then the ability to
retrieve 76%, or approximately 2.28 million specimens,
of rare tumor cases signifies a rate of success that would be
adequate to support research in a wide variety of experi-
ments. Table 9 also reveals that 71% of all the blocks of
rare tumors cases found represented blocks with tumor
tissue present. It is also important to note that many of
these specimens have multiple blocks associated with
them, which further increases the number of individual
blocks available for research.
Many studies will require comparison to normal controls.
This study does not evaluate the availability of such con-
trols but, given the high prevalence of non-cancer speci-
mens in our collective archives, we believe that there will
be several different sources of normal tissues. Of course
the definition of "normal" will differ as a function of the
questions asked in each study.
Conclusion
Pre-existing archives of tissue blocks routinely saved in
pathology departments are adequate sources of tissue
blocks that can be used in many types of research efforts.
The need for tools such as SPIN is indicated by the grow-
ing use of tissues, diagnostic specimens, and their related
clinical data in biomedical research. Our results demon-
strate that significant retrieval rates (all blocks), when
measured by the total number of available blocks, are pos-
sible for acquiring both common (89%) and rare tumors
(76%). And despite the various search methods utilized in
this study to identify cases, this study does show the pos-
sibility of finding an adequate number of cases with par-
affin blocks (of both tumor tissue as well as adjacent
normal tissue) as far back as 1990 that could be useful for
the research community. This assessment shows that indi-
vidual institutions can utilize electronic data to search for
archival tissues which are of interest to researchers. As a
follow up to this study, we intend on solely using SPIN
tools in order to estimate the resources required to use
SPIN alone and to determine what sample yield that
restriction generates.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Table 5: Average size of tumor present in tissue blocks. The average size of tumor present on the blocks for common tumor types 
retrieved and reported from a pool of 400 cases from all SPIN centers. Common Tumors
Tumor Size Largest block containing tumor (cm) 2nd largest block with tumor (cm) 3rd largest block with tumor (cm)
n 293 258 211
AVERAGE 1.487 1.232 1.038
MAX 2.5 2.5 2.5
MIN 0.1 0.1 0.1
STDEV 0.753 0.765 0.756Page 8 of 14
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Availability of slides and/or blocks with tumorFigure 2
Availability of slides and/or blocks with tumor. Illustration of the availability of slides and/or blocks with the presence of 
tumor tissue from individual SPIN centers in (a) common tumor cases and (b) rare tumor cases.
(a) Common Tumors
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Distribution of retrieved cases for the common tumorsFigure 3
Distribution of retrieved cases for the common tumors. Illustration of number of cases retrieved for common tumor 
cases by the original year of accession: (a) Breakdown by each institution and (b) by common tumor type*. Specimens retrieved 
and evaluated for the common tumors encompassed cases accessioned range from 1990–1999 with 64% being at least 10 years 
old.
a) Distribution of retrieved common tumor cases by accession year from each SPIN 
institution. 
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 b) Distribution of retrieved cases by accession year of each common tumor type.* 
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Table 6: Availability of slides/blocks from tissue archives of rare tumors. Summary of the availability of slides and blocks retrieved from 
all SPIN sites with a breakdown of the number of blocks with presence of tumor for cases in the rare tumor type category.
Quantity # of cases found on 
search: slides 
available by path 
report
# of cases found on 
search: slides found 
in archive
# of cases found on 
search: blocks 
available by path 
report
# of cases found on 
search: all blocks 
found in archive
# of cases found on 
search: Blocks w/
Tumor found in 
archive
n/a* 114 18 42 18 95
0 0 71 16 80 41
1 – 3 78 81 114 109 146
4 – 6 34 43 50 44 41
7 – 9 21 25 34 30 27
10 – 14 37 56 58 49 41
15 – 19 45 35 42 38 8
20 – 29 42 43 30 23 1
30 – 39 17 18 12 8 0
>40 12 10 2 1 0
400 400 400 400 400
n/a * = not available, blocks only, no tumor seen
Table 8: Retrieval rates for rare tumors. Retrieval rate from all SPIN sites for the rare tumor type category: Percentage case retrieval 
by each SPIN institution (cases/total cases); Case retrieval rate at each SPIN institution for rare tumors. (cases/total cases)
n = 100 n = 100 n = 100 N = 100
Pitt UCLA IU Harvard
% case retrieval (all blocks) 67% 84% 73% 78%
% case retrieval (Blocks with Tumor) 42% 76% 76% 70%
Table 7: Retrieval rates for rare tumors. Retrieval rate from all SPIN sites for the rare tumor type category: Percentage case retrieval 
by each rare tumor type (cases/total cases). Case retrieval rate for each tumor types in the rare tumors category. (cases/total cases)
n = 100 n = 100 n = 100 n = 100 n = 400
Adenoid Cystic Carcinoma Adrenal Cortical Ca GIST Mycosis Fungoides ALL Rare Cases
% case retrieval (all blocks) 66% 71% 82% 83% 76%
% case retrieval (Blocks with Tumor) 58% 65% 72% 69% 66%
Table 9: Retrieval rates for rare tumors. Retrieval rate from all SPIN sites for the rare tumor type category: Breakdown by each rare 
tumor type at each institution (tumor blocks/all blocks). Retrieval rate for blocks with the presence of tumor for each rare tumor type 
category at each of the SPIN institution. (tumor blocks/all blocks)
n = 25 n = 25 n = 25 n = 25 n = 100
SPIN INSTITUTIONS Adenoid Cystic Carcinoma Adrenal Cortical Ca GIST Mycosis Fungoides ALL Rare Cases
PITTSBURGH 4% 96% 64% 80% 61%
UCLA 88% 36% 100% 80% 76%
INDIANA 68% 80% 80% 76% 76%
HARVARD 72% 60% 76% 72% 70%
ALL SPIN SITES 58% 68% 80% 77% 71%
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Table 10: Average size of tumor present in tissue blocks. The average size of tumor present on the blocks for rare tumor types 
retrieved and reported from a pool of 400 cases from all SPIN centers. Rare Tumors
Tumor Size Largest block containing tumor (cm) 2nd largest block with tumor (cm) 3rd largest block with tumor (cm)
n 286 221 167
AVERAGE 1.555 1.523 1.596^
MAX 2.6 2.7 2.8
MIN 0.1 0.1 0.1
STDEV 0.854 0.820 0.726
^The average size is based on all cases that reported the third block. Cases with large volume tumors had many blocks with large sizes of tumor (≥3 
blocks), whereas, small volume tumors had fewer blocks with tumor available (< 3 blocks). The total number of the 3rd block with the presence of 
tumor was many from large volume tumors, thus the higher average size compared to largest block #1.
Distribution of retrieved cases for rare tumorsFigure 4
Distribution of retrieved cases for rare tumors. Illustration of number of cases retrieved for rare tumor cases by the orig-
inal year of accession for that case: (a) Breakdown by each institution and (b) by rare tumor type*. Specimens retrieved and 
evaluated for the rare tumors encompassed cases accessioned range from 1988–2005 with 62% being greater than 5 years old.
(a) Distribution of retrieved rare tumor cases by accession year from each SPIN institution. 
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(b) Distribution of retrieved cases by accession year of each rare tumor type.* 
Distribution of Retrieved Cases (Rare Tumors)
0
10
20
30
40
50
60
70
80
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
Accession year
# 
o
f 
ca
se
s 
fo
u
n
d
 
Mycosis Fungoides
GIST
Adrenal Cortical CA
Adenoid Cystic CA
 * Data from 3 of 4 SPIN institutions. 
BMC Cancer 2007, 7:37 http://www.biomedcentral.com/1471-2407/7/37Authors' contributions
AAP and AVP contributed equally to the first draft of this
manuscript. The Pittsburgh Team did the overall coordi-
nation and design of the study. DG, DS, EMH, UJB, TMU,
SD, OS, and HY did the pathology review. MJB, ISK, JJB,
and JRG were project liaisons from the SPIN Coordinating
Committee. All authors reviewed and commented on suc-
cessive drafts of the manuscript and approved the final
manuscript to the first author.
Acknowledgements
We acknowledge all the following contributors for technical and logistical 
support of this study (in alphabetical order by last name):
Cancer Diagnosis Program NCI/NIH: Roger Aamodt and Sheila Taube.
Harvard University: Ana Holzbach and Henry Chueh.
Indiana University: Tracey Bender, site coordinator for case collections and 
Lonnie Blevins performed the SPIN query for case selections.
University of California Los Angeles: Leslie Ingram-Drake performed the 
electronic case searches. Cassandra Lamb, Sheila Tze, and Cindy Yuge 
helped in case collections.
University of Pittsburgh: Tissue bank support by Mindy Arnold, Michelle 
Bisceglia, Patricia Clark, Aprell Delo, Sambit Mohanty, and also Susan Urda, 
the lead cancer registrar, for performing the electronic case selections.
Grant support: National Cancer Institute Grants U01CA091429, 
U01CA091343 and UO1CA91338-01.
References
1. Abati A, Liotta LA: Looking forward in diagnostic pathology:
the molecular superhighway.  Cancer 1996, 78(1):1-3.
2. Fetsch PA, Simone NL, Bryant-Greenwood PK, Marincola FM, Filie
AC, Petricoin EF, Liotta LA, Abati A: Proteomic evaluation of
archival cytologic material using SELDI affinity mass spec-
trometry: potential for diagnostic applications.  Am J Clin Pathol
2002, 118(6):870-876.
3. Shared Pathology Informatics Network: Release Date:
March 27, 2000, RFA: CA-01-006, National Cancer Institute
[http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-01-006.html]
4. Becich MJ: The role of the pathologist as tissue refiner and
data miner: the impact of functional genomics on the mod-
ern pathology laboratory and the critical roles of pathology
informatics and bioinformatics.  Mol Diagn 2000, 5(4):287-299.
5. Shared Pathology Informatics Network website   [http://
www.cancerdiagnosis.nci.nih.gov/spin/]
6. Marshall E: Panel proposes tighter rules for tissue studies.  Sci-
ence 1998, 282(5397):2165-2166.
7. Mizuno T, Nagamura H, Iwamoto KS, Ito T, Fukuhara T, Tokunaga M,
Tokuoka S, Mabuchi K, Seyama T: RNA from decades-old archi-
val tissue blocks for retrospective studies.  Diagn Mol Pathol
1998, 7(4):202-208.
8. Qualman SJ, France M, Grizzle WE, LiVolsi VA, Moskaluk CA, Rami-
rez NC, Washington MK: Establishing a tumour bank: banking,
informatics and ethics.  Br J Cancer 2004, 90(6):1115-1119.
9. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Hen-
ning JM, Carroll PR: The contemporary management of pros-
tate cancer in the United States: lessons from the cancer of
the prostate strategic urologic research endeavor (Cap-
SURE), a national disease registry.  J Urol 2004,
171(4):1393-1401.
10. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R,
Carroll PR: The CaPSURE database: a methodology for clini-
cal practice and research in prostate cancer. CaPSURE
Research Panel. Cancer of the Prostate Strategic Urologic
Research Endeavor.  Urology 1996, 48(5):773-777.
11. Grizzle W, Grody WW, Noll WW, Sobel ME, Stass SA, Trainer T,
Travers H, Weedn V, Woodruff K: Recommended policies for
uses of human tissue in research, education, and quality con-
trol. Ad Hoc Committee on Stored Tissue, College of Amer-
ican Pathologists.  Arch Pathol Lab Med 1999, 123(4):296-300.
12. Grizzle WE, Aamodt R, Clausen K, LiVolsi V, Pretlow TG, Qualman
S: Providing human tissues for research: how to establish a
program.  Arch Pathol Lab Med 1998, 122(12):1065-1076.
13. Grizzle WE, Woodruff KH, Trainer TD: The pathologist's role in
the use of human tissues in research--legal, ethical, and other
issues.  Arch Pathol Lab Med 1996, 120(10):909-912.
14. Wertz DC: Archived specimens: a platform for discussion.
Community Genet 1999, 2(2-3):51-60.
15. Becich MJ, Gilbertson JR, Gupta D, Patel A, Grzybicki DM, Raab SS:
Pathology and patient safety: the critical role of pathology
informatics in error reduction and quality initiatives.  Clin Lab
Med 2004, 24(4):913-43, vi.
16. Melamed J, Datta MW, Becich MJ, Orenstein JM, Dhir R, Silver S, Fide-
lia-Lambert M, Kadjacsy-Balla A, Macias V, Patel A, Walden PD, Bos-
land MC, Berman JJ: The cooperative prostate cancer tissue
resource: a specimen and data resource for cancer research-
ers.  Clin Cancer Res 2004, 10(14):4614-4621.
17. Patel AA, Kajdacsy-Balla A, Berman JJ, Bosland M, Datta MW, Dhir R,
Gilbertson J, Melamed J, Orenstein J, Tai KF, Becich MJ: The devel-
opment of common data elements for a multi-institute pros-
tate cancer tissue bank: the Cooperative Prostate Cancer
Tissue Resource (CPCTR) experience.  BMC Cancer 2005,
5:108.
18. Glass AG, Donis-Keller H, Mies C, Russo J, Zehnbauer B, Taube S,
Aamodt R: The Cooperative Breast Cancer Tissue Resource:
archival tissue for the investigation of tumor markers.  Clin
Cancer Res 2001, 7(7):1843-1849.
19. AIDS and Cancer Specimen Resource   [http://acsb.ucsf.edu/]
20. Patel AA, Gilbertson JR, Parwani AV, Dhir R, Datta MW, Gupta R,
Berman JJ, Melamed J, Kajdacsy-Balla A, Orenstein J, Becich MJ: An
informatics model for tissue banks - Lessons learned from
the Cooperative Prostate Cancer Tissue Resource.  BMC Can-
cer 2006, 6(1):120.
21. Beckwith BA, Mahaadevan R, Balis UJ, Kuo F: Development and
evaluation of an open source software tool for deidentifica-
tion of pathology reports.  BMC Med Inform Decis Mak 2006, 6:12.
22. Gupta D, Saul M, Gilbertson J: Evaluation of a deidentification
(De-Id) software engine to share pathology reports and clin-
ical documents for research.  Am J Clin Pathol 2004,
121(2):176-186.
23. McDonald CJ, Dexter P, Schadow G, Chueh HC, Abernathy G, Hook
J, Blevins L, Overhage JM, Berman JJ: SPIN query tools for de-
identified research on a humongous database.  AMIA Annu
Symp Proc 2005:515-519.
24. Mitchell KJ, Becich MJ, Berman JJ, Chapman WW, Gilbertson J, Gupta
D, Harrison J, Legowski E, Crowley RS: Implementation and eval-
uation of a negation tagger in a pipeline-based system for
information extract from pathology reports.  Medinfo 2004,
11(Pt 1):663-667.
25. Mitchell KJ, Crowley RS, Gupta D, Gilbertson J: A knowledge-
based approach to information extraction from surgical
pathology reports.  AMIA Annu Symp Proc 2003:937.
26. Namini AH, Berkowicz DA, Kohane IS, Chueh H: A submission
model for use in the indexing, searching, and retrieval of dis-
tributed pathology case and tissue specimens.  Medinfo 2004,
11(Pt 2):1264-1267.
27. Schadow G, McDonald CJ: Extracting structured information
from free text pathology reports.  AMIA Annu Symp Proc
2003:584-588.
28. Gilbertson JR, Gupta R, Nie Y, Patel AA, Becich MJ: Automated
clinical annotation of tissue bank specimens.  Medinfo 2004,
11(Pt 1):607-610.
29. Holzbach AM, Chueh H, Porter AJ, Kohane IS, Berkowicz D: A
query engine for distributed medical databases.  Medinfo 2004,
11:1519.Page 13 of 14
(page number not for citation purposes)
BMC Cancer 2007, 7:37 http://www.biomedcentral.com/1471-2407/7/37Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/7/37/prepubPage 14 of 14
(page number not for citation purposes)
